Alankar Garude

Ankur, do you still expect to grow overall sales in FY '26?

Okay. I asked this Ankur because you had said that there would be growth at overall level in FY '26. But okay, I take your point. Second question is, can you broadly break down the API growth across pricing, volumes and new launches for 9 month FY '26?

Within those 28, 29 existing molecules, how would you break the growth between volumes and pricing? Just a qualitative response should suffice?